Compliance certificate for Q2 FY27 dematerialisation under SEBI Reg 74(5)

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.1%Reaction day

₹94.00

prior close

₹88.65

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+5.2% vs market

Pharmaceuticals peers, median of 167sector-0.1%+6.2% vs sector

On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 6.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+11.4

30m

+11.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.1+0.8+5.2-0.1+6.2

Next day

+11.7+1.0+10.7-0.1+11.8

+17.0+1.7+15.2-0.3+17.3

+22.3+0.1+22.3-1.0+23.3

+22.3+0.8+21.6-0.8+23.2

+22.3-0.9+23.2-2.3+24.6

+15.2-4.5+19.7-4.7+19.9

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Starsource Multitrade submitted a quarterly compliance certificate under SEBI Regulation 74(5) for Q2 FY27 (July to September 2026). The company's RTA Purva Sharegistry confirmed processing of 8 dematerialisation requests covering 400 shares from 4 shareholders. This is a routine procedural filing confirming dematerialisation activities were completed within prescribed timelines.

Likely market impact

Routine regulatory filing with no material impact on shareholders or stock price.